SAR1B (SAR1 homolog B (S. cerevisiae), ANDD, CMRD, GTBPB, GTP-binding protein Sara, SARA2, SARB, SAR1a gene homolog 2) (Control Peptide)

Catalog No : USB-S0098-07D-P
421.85€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name SAR1B (SAR1 homolog B (S. cerevisiae), ANDD, CMRD, GTBPB, GTP-binding protein Sara, SARA2, SARB, SAR1a gene homolog 2) (Control Peptide)
Catalog No USB-S0098-07D-P
Supplier’s Catalog No S0098-07D-P
Supplier US Biologicals
Source antigen Synthetic
Reactivity
Cross reactivity
Applications
Molecular weight
Storage -20°C
Other names
Grade Highly Purified
Purity Highly Purified
Form Supplied as a lyophilized powder in PBS. Reconstitution: Reconstitute with 200ul sterile ddH2O.
Reactivity life 12 months
Note For reserch purpose only
Purity Highly Purified
Description C-DHERLLESKEELD, from the internal region of mouse SAR1B. Control peptide corresponding to polyclonal antibody, Catalog#S0098-07D, goat x mouse. SAR1B is involved in transport from the endoplasmic reticulum to the Golgi apparatus. Activated by the guanine nucleotide exchange factor PREB. Involved in the selection of the protein cargo and the assembly of the COPII coat complex. Defects in SAR1B are the cause of chylomicron retention disease (CMRD) [MIM:246700]; also known as Anderson disease (ANDD). CMRD is an autosomal recessive disorder of severe fat malabsorption associated with failure to thrive in infancy. The condition is characterized by deficiency of fat-soluble vitamins, low blood cholesterol levels, and a selective absence of chylomicrons from blood. Affected individuals accumulate chylomicron-like particles in membrane-bound compartments of enterocytes, which contain large cytosolic lipid droplets. Applications: Suitable for use in ELISA. Other applications not tested. Recommended Dilutions: Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot and store at -20°C. Aliquots are stable for at least 12 monthsat -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. Peptide Blocking (see corresponding antibody S0098-07D): Antibodies are typically supplied at 0.5mg/ml and peptides as a 100ul pellet. When peptides are reconstituted in 200ul water, the concentration would be also 0.5mg/ml. To start, the best ratio would be 1:1 (which means molar excess of peptides relative to antibodies when identical volumes are mixed). Mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. It is best is to have two identical blots, to be incubated with equal amount of antibodies, but one with the antibodies pre-adsorbed to the peptide for 20min. Then incubate and develop the two blots in parallel.